Prenetics Global Limited
NASDAQ Global MarketTotal Valuation
Prenetics Global Limited carries a market capitalization of 224,827.00, placing it among publicly traded companies globally. Its enterprise value stands at -61.65M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 224,827.00 |
| Enterprise Value | -61.65M |
Share Statistics
Prenetics Global Limited currently has 16.73M shares outstanding.
| Shares Outstanding | 16.73M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Financial Position
Prenetics Global Limited maintains a current ratio of 2.97, meaning it holds 3.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 1.13, indicating moderate leverage, while an interest coverage ratio of -173.11 demonstrates limited ability to service its debt obligations.
| Current Ratio | 2.97 |
| Quick Ratio | 2.35 |
| Debt / Equity | 1.13 |
| Debt / EBITDA | -0.04 |
| Interest Coverage | -173.11 |
Financial Efficiency
| Return on Equity (ROE) | -736,906.97 |
| Return on Assets (ROA) | -17.97 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 6.60 |
Taxes
| Income Tax | -50,000.00 |
| Effective Tax Rate | N/A |
Stock Price Statistics
Prenetics Global Limited's stock has gained approximately 25% over the past 52 weeks. The 50-day moving average sits at 0.02, while the 200-day moving average is 0.03.
| Beta (5Y) | N/A |
| 52-Week Price Change | 25% |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.03 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -40.51M, while operating income came in at -40.51M.
| Revenue | 95.11M |
| Gross Profit | 50.24M |
| Operating Income | -40.51M |
| Pretax Income | -38.46M |
| Net Income | -37.71M |
| EBITDA | -40.51M |
| EBIT | -40.51M |
| Earnings Per Share (EPS) | N/A |
Balance Sheet
Prenetics Global Limited holds 63.32M in cash and equivalents against 1.77M in total debt, resulting in a net debt position of -32.13M. Total book value stands at -554.76M, with working capital of 56.48M providing operational flexibility.
| Cash & Cash Equivalents | 63.32M |
| Total Debt | 1.77M |
| Net Debt | -32.13M |
| Equity (Book Value) | -554.76M |
| Book Value Per Share | N/A |
| Working Capital | 56.48M |
Margins
Prenetics Global Limited operates with a gross margin of 52.83, reflecting its pricing power and cost economics. The operating margin of -42.59 and net profit margin of -39.65 provide insight into operational efficiency.
| Gross Margin | 52.83 |
| Operating Margin | -42.59 |
| Pretax Margin | -40.44 |
| Profit Margin | -39.65 |
| EBITDA Margin | -42.59 |
Scores
Prenetics Global Limited posts an Altman Z-Score of -3.65, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -3.65 |